Amanote Research
Register
Sign In
Mismatch Repair Protein Deficiency Is a Risk Factor for Aberrant Expression of HLA Class I Molecules: A Putative "Adaptive Immune Escape" Phenomenon
Anticancer Research
- Greece
doi 10.21873/anticanres.11446
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Date
March 17, 2017
Authors
Unknown
Publisher
International Institute of Anticancer Research
Related search
Mismatch Repair Deficiency Is a Rare but Putative Therapeutically Relevant Finding in Non-Liver Fluke Associated Cholangiocarcinoma
British Journal of Cancer
Cancer Research
Oncology
A Common Minimal Motif for the Ligands of HLA-B*27 Class I Molecules
PLoS ONE
Multidisciplinary
Characterization of LGR5 Expression in Poorly Differentiated Colorectal Carcinoma With Mismatch Repair Protein Deficiency
BMC Cancer
Cancer Research
Oncology
Genetics
CIITA-related Block of HLA Class II Expression, Upregulation of HLA Class I, and Heterogeneous Expression of Immune Checkpoints in Hepatocarcinomas: Implications for New Therapeutic Approaches
OncoImmunology
Oncology
Allergy
Immunology
Downregulation of HLA Class I Expression by C-Myc in Human Melanoma Is Independent of Enhancer A
Nucleic Acids Research
Genetics
Association of HLA-A and Non-Classical HLA Class I Alleles
PLoS ONE
Multidisciplinary
Cholecystectomy and the Risk of Colorectal Cancer by Tumor Mismatch Repair Deficiency Status
International Journal of Colorectal Disease
Gastroenterology
The HLA-G Non Classical MHC Class I Molecule Is Expressed in Cancer With Poor Prognosis. Implications in Tumour Escape From Immune System and Clinical Applications
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
A Single Endoplasmic Reticulum Aminopeptidase-1 Protein Allotype Is a Strong Risk Factor for Behçet's Disease in HLA-B*51 Carriers
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
